Clinical Trials Browser

Pancreatic Neoplasms × sotigalimab × 90 days × Clear all

NCT05419479 2026-06-04

Switch Maintenance in Pancreatic

Phase 1/2 Suspended

Gastrointestinal

Pancreatic Neoplasms